Section 32
Facts
- HQ
- California
- Sectors
- Venture capital, Biotech, Technology, Healthcare, Life sciences
AltPep Raises $52.9M to Advance Early Detection and Treatments for Alzheimer’s and Parkinson’s Diseases
AltPep, a University of Washington spinout developing tests and treatments for Alzheimer’s and Parkinson’s, raised $52.9 million in Series B funding to advance clinical trials and regulatory approval for its early detection blood test. The company targets toxic oligomers linked to Alzheimer’s and a related protein in Parkinson’s, aiming to enable early screening and preventive treatment.
Phaidra raises $4M led by Flying Fish with Mark Cuban among investors to scale AI for industrial automation
Phaidra, a 15-person startup founded in 2019 that builds AI agents to analyze sensor data and optimize industrial facilities, raised $4 million led by Flying Fish with participation from Section 32, Character, Starshot Capital and Mark Cuban. The company — led by ex-DeepMind engineers Jim Gao and Vedavyas Panneershelvam and industry veteran Katherine Hoffman — will use the funding to expand in process heating/cooling, chemical manufacturing and paper and pulp.
TwinStrand Biosciences, led by Jesse Salk, raises $50M Series B from Section 32 to scale ultra-accurate gene-sequencing
TwinStrand Biosciences, co-founded and led by Jesse Salk, raised $50 million in a Series B led by Section 32 to expand its high-accuracy gene-sequencing technology for detecting rare mutations with applications in cancer detection, therapy monitoring, and safety testing.
Ex-DeepMind Engineers’ Startup Phaidra Raises $1.5M to Build In-House AI for Industrial Customers, Launches in Seattle
Stealth startup Phaidra, founded by ex-DeepMind engineers Jim Gao and Vedavyas Panneershelvam with industry veteran Katherine Hoffman, raised $1.5 million to build AI tools that let industrial companies develop in-house models while retaining data and IP. The four-person company chose Seattle for its mix of tech ecosystem and industrial roots and is currently building a beta product.
